RPT-Vice Media takes its edgy journalism to the Middle East
DUBAI, March 29 Vice Media is bringing its edgy style of journalism to the Middle East to tap what it believes is an underserved market of young, digital hungry consumers.
Feb 22 U.S. health regulators said on Friday they have approved a new drug made by Roche Holding AG for some patients with late-stage metastatic breast cancer who have failed other therapies.
The U.S. Food and Drug Administration said it approved Kadcyla, also known as ado-trastuzumab emtansine, for patients whose cancer cells contain increased amounts of a protein known as HER2.
The drug's label will carry a boxed warning, the most serious possible, of the drug's potential to cause liver and heart toxicity and death. The drug can also cause life-threatening birth defects.
In clinical trials, patients who took the drug, known during its development process as T-DM1, survived an average of 30.9 months, compared with 25.1 months in the control group.
(Adds comment, detail, updates prices) MELBOURNE, March 30 London copper slipped on Thursday in low-volume trade as the dollar held gains on brighter economic signals from the United States and traders waited for further U.S. and China economic cues for direction. With the U.S. economy having now "largely attained" a full recovery from recession, the Federal Reserve can raise interest rates three or more times this year, a centrist Fed policymaker said on Wednesday, helping